Nasal Spray Fill/Finish Machine
TurboFil Packaging Machines Mini-Monoblock MDN-50 is designed to accurately and expediently fill, seal, cap, and label spray multi-dose nasal dispensers.
TurboFil Packaging Machines’ Mini-Monoblock MDN-50
TurboFil Packaging Machines’ Mini-Monoblock MDN-50 fill/finish machine is designed to accurately and expediently fill, seal, cap, and label spray multi-dose nasal dispensers. The machine is suitable for vials with volumes from 4 to 30 mL and can process containers at a rate of up to 50 pieces per minute. It can be used with containers with tamp, crimp, and screw closures.
The machine uses a scroll conveyor designed to enable seamless vial loading while also allowing for a compact overall footprint. Vials are then transported to a starwheel ceramic piston filler station for clean and accurate filling; a second nozzle can be incorporated in the filler station for faster filling. Following this, the filled and sealed vials are conveyed to an optional wrap-around labeler with a thermal transfer printer that can apply lot code, manufacture/expiry dates, and other necessary information.
The Mini-Monoblock MDN-50 features a 7-in. touchscreen human–machine interface and escalating password levels for tiered personnel access. A three-color stack light with an audible alarm can alert personnel to potential issues, while ethernet capability allows for remote diagnostics.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.
